Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Free Radical Biology & Medicine|May 5, 2011
Peroxiredoxin 2 in the nucleus and cytoplasm distinctly regulates androgen receptor activity in prostate cancer cellsMasaki Shiota, Akira Yokomizo, Eiji Kashiwagi, et al.
The Journal of Urology|October 30, 2010
Mechanism of synergistic antitumor effect of sorafenib and interferon-α on treatment of renal cell carcinomaArio Takeuchi, Masatoshi Eto, Katsunori Tatsugami, et al.
Molecular Medicine Reports|September 22, 2011
p300 mediates cellular resistance to doxorubicin in bladder cancerArio Takeuchi, Masaki Shiota, Katsunori Tatsugami, et al.
Andrologia|August 8, 2018
Serum testosterone before and during androgen-deprivation therapy, and prognosis between cigarette smokers and nonsmokers with metastatic prostate cancerMasaki Shiota, Eiji Kashiwagi, Tomohiko Murakami, et al.
Urologic Oncology|November 18, 2018
Serum testosterone level as possible predictive marker in androgen receptor axis-targeting agents and taxane chemotherapies for castration-resistant prostate cancerMasaki Shiota, Eiji Kashiwagi, Tomohiko Murakami, et al.
Journal of Surgical Oncology|June 6, 2014
The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomyMasaki Shiota, Akira Yokomizo, Ario Takeuchi, et al.
Microbiology and Immunology|October 10, 2013
A C-type lectin receptor pathway is responsible for the pathogenesis of acute cyclophosphamide-induced cystitis in miceTakashi Dejima, Kensuke Shibata, Hisakata Yamada, et al.
International Immunopharmacology|October 1, 2009
Oral administration of xanthan gum enhances antitumor activity through Toll-like receptor 4Ario Takeuchi, Yoriyuki Kamiryou, Hisakata Yamada, et al.
Cancer Immunology, Immunotherapy : CII|March 4, 2020
Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancerMasaki Shiota, Naohiro Fujimoto, Yoshiaki Yamamoto, et al.
The Prostate|August 19, 2010
Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cellsAkira Yokomizo, Masaki Shiota, Eiji Kashiwagi, et al.
Pageof 12